Povero, M., Pradelli, L., Serra, A., Fanelli, F., & Gazzi, L. (2021). Cost-Effectiveness Analysis of Alirocumab in High Cardiovascular-Risk Patients in Italy. Farmeconomia. Health Economics and Therapeutic Pathways, 22(1). https://doi.org/10.7175/fe.v22i1.1499